Recent Articles
STARTER Pathological IHC Antibod...
Dual-Defect Nitrogen-Rich Carbon...
Bile Acid Receptor FXR Regulatin...
STARTER Pathological IHC Antibodies Facilitate Research on APOE+ Tumor-Associ...
The study titled APOE deficiency triggers anti-tumour activity of macrophages in liver cancer was published in the Nature sub-journal Cancer Gene Therapy. Led by Xintong Xia from Zhejiang Chinese Medical...
STARTER Pathological IHC Antibodies Facilitate Research on APOE+ Tumor-Associ...
The study titled APOE deficiency triggers anti-tumour activity of macrophages in liver cancer was published in the Nature sub-journal Cancer Gene Therapy. Led by Xintong Xia from Zhejiang Chinese Medical...
Read More
Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst:...
In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low tumor immunogenicity, insufficient immune infiltration, and an immunosuppressive microenvironment. A...
Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst:...
In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low tumor immunogenicity, insufficient immune infiltration, and an immunosuppressive microenvironment. A...
Read More
Bile Acid Receptor FXR Regulating Intestinal Epithelial Ferroptosis
Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very low birth weight infants worldwide is approximately 7%, and the...
Bile Acid Receptor FXR Regulating Intestinal Epithelial Ferroptosis
Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very low birth weight infants worldwide is approximately 7%, and the...
Read More
How Does CCR8+Treg Targeted Therapy Overcome PD1 Resistance?
Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in...
How Does CCR8+Treg Targeted Therapy Overcome PD1 Resistance?
Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in...
Read More
Absin IHC Kit Facilitates Key Discoveries in Osteosarcoma Cisplatin Resistanc...
In the field of cancer treatment, osteosarcoma, as the most common primary malignant bone tumor in children and adolescents, has long been limited by cisplatin (DDP) resistance in its treatment....
Absin IHC Kit Facilitates Key Discoveries in Osteosarcoma Cisplatin Resistanc...
In the field of cancer treatment, osteosarcoma, as the most common primary malignant bone tumor in children and adolescents, has long been limited by cisplatin (DDP) resistance in its treatment....
Read More
Lung Cancer Prevention and Treatment: Absin Empowers the Development of Inhal...
As a malignant tumor with both high global incidence and mortality rates, lung cancer has long been a key focus in the field of medical research. Recently, a study titled A...
Lung Cancer Prevention and Treatment: Absin Empowers the Development of Inhal...
As a malignant tumor with both high global incidence and mortality rates, lung cancer has long been a key focus in the field of medical research. Recently, a study titled A...
Read More